Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single-nucleus RNA sequencing reveals transcriptional heterogeneity in the blastema of favorable-histology Wilms tumor
Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller
Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller
View: Text | PDF
Research Article Development Nephrology Oncology

Single-nucleus RNA sequencing reveals transcriptional heterogeneity in the blastema of favorable-histology Wilms tumor

  • Text
  • PDF
Abstract

While Wilms tumors commonly arise from renal precursor cells and maintain features of the developing kidney, recent studies have demonstrated substantial genetic, histologic, and molecular heterogeneity. To further investigate tumor variability as well as unifying features in tumor biology, we performed single-nucleus RNA sequencing (snRNA-seq) on treatment-naive, favorable-histology Wilms tumors utilizing a reference atlas established from tumor-adjacent kidney samples and fetal kidney. Transcriptional profiles of blastemal, stromal, and epithelial components were correlated with tumor histology and demonstrated developmental-lineage plasticity, with PAX2 and PAX8 expression normally restricted to the nephron lineage of the fetal kidney found to be expressed in tumor stroma, as well as the stromal marker POSTN identified in tumor blastema. Further analyses of the blastema show shared transcriptional features with the differentiation trajectory of “uninduced” to “early differentiating” fetal nephron progenitor cells as well as aberrant expression of stromal signatures. A number of pathways from fetal nephron progenitors were maintained in the blastema, including regulation of stem cell maintenance and axonogenesis, whereas other pathways appear enriched in specific tumor samples, demonstrating the ability of snRNA-seq to identify both unifying transcriptional signatures and uncover distinct molecular targets in signaling pathways and/or biological drivers of Wilms tumorigenesis.

Authors

Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller

×

Figure 2

Histological examination of tumor samples correlates with cell types captured via snRNA-seq, with the exception of tumors T1 and T4.

Options: View larger image (or click on image) Download as PowerPoint
Histological examination of tumor samples correlates with cell types cap...
(A) H&E images of the fetal kidney compared to Wilms tumor samples show similar histological features. In the human fetal kidney, nephron progenitor cells (asterisks), early differentiating nephron structures (arrowheads), and early tubules (arrows) localize to the outer nephrogenic zone of the developing kidney, with Wilms tumors known to maintain features of these fetal cells. Representative H&E images of human fetal kidney and selected tumors are shown here. Original magnification, ×10 (left) and ×20 (right). Scale bars: 100 μm. (B) Tumor histology was scored by a pathologist to quantify the percentage of blastemal, epithelial, and stromal compartments from each sample. While the majority of tumors showed correlation between the tumor components captured via snRNA-seq and the histological score, there were discrepancies noted for T1, which showed interstitial (i.e., stromal) predominance by histology versus blastemal predominance by snRNA-seq and for T4, which showed epithelial predominance by histology versus blastemal predominance by snRNA-seq. (C) Evaluation of the specific cell types captured (i.e., percentage cell type) is shown for each sample, demonstrating populations of cells along the spectrum of the nephron lineage, including undifferentiated NPCs to RVs/pretubules, found to within tumor samples. NPC, nephron progenitor cell; RV, renal vesicle; CNT, connecting tubule; DT, distal tubule; CD-P, collecting duct principal cell; CD-I, collecting duct intercalated cell; LoH, loop of Henle; tdlLOH, thick descending limb of loop of Henle; PT, proximal tubule.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts